Protein kinase C phosphorylates pp60src at a novel site. Gould KL, Woodgett JR, Cooper JA, Buss JE, Shalloway D, Hunter T (1985) Cell 42: 849-57 The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Hann SR, Dixit M, Sears RC, Sealy L (1994) Genes Dev 8: 2441-52 The 46,000-dalton tyrosine protein kinase substrate is widespread, whereas the 36,000-dalton substrate is only expressed at high levels in certain rodent tissues. Gould KL, Cooper JA, Hunter T (1984) J Cell Biol 98: 487-97 Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus. Reynolds AB, Vila J, Lansing TJ, Potts WM, Weber MJ, Parsons JT (1987) EMBO J 6: 2359-64 PDGF, CSF-1, and EGF induce tyrosine phosphorylation of p120, a pp60src transformation-associated substrate. Downing JR, Reynolds AB (1991) Oncogene 6: 607-13 Maximal serum stimulation of the c-fos serum response element requires both the serum response factor and a novel binding factor, SRE-binding protein. Boulden AM, Sealy LJ (1992) Mol Cell Biol 12: 4769-83 Stable association of activated pp60src with two tyrosine-phosphorylated cellular proteins. Reynolds AB, Kanner SB, Wang HC, Parsons JT (1989) Mol Cell Biol 9: 3951-8 Purification and properties of the Rous sarcoma virus internal enhancer binding factor. Karnitz L, Poon D, Weil PA, Chalkley R (1989) Mol Cell Biol 9: 1929-39 Multiple forms of C/EBP beta bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat. Sears RC, Sealy L (1994) Mol Cell Biol 14: 4855-71 Glycoprotein tyrosine phosphorylation in Rous sarcoma virus-transformed chicken embryo fibroblasts. Kozma LM, Reynolds AB, Weber MJ (1990) Mol Cell Biol 10: 837-41 Role of the transcription start site core region and transcription factor YY1 in Rous sarcoma virus long terminal repeat promoter activity. Mobley CM, Sealy L (1998) J Virol 72: 6592-601 The Rous sarcoma virus long terminal repeat promoter is regulated by TFII-I. Mobley CM, Sealy L (2000) J Virol 74: 6511-9 Characterization of nuclear proteins that bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat. Sears RC, Sealy L (1992) J Virol 66: 6338-52 Analysis of the competition between nucleosome formation and transcription factor binding. Svaren J, Klebanow E, Sealy L, Chalkley R (1994) J Biol Chem 269: 9335-44 Rous sarcoma virus enhancer factor I is a ubiquitous CCAAT transcription factor highly related to CBF and NF-Y. Faber M, Sealy L (1990) J Biol Chem 265: 22243-54 Identification and purification of a yeast transcriptional trans-activator. The yeast homolog of the Rous sarcoma virus internal enhancer binding factor. Karnitz L, Poon D, Weil PA, Chalkley R (1990) J Biol Chem 265: 6131-8 Adenovirus-mediated gene transfer during initial organogenesis in the mammalian embryo is promoter-dependent and tissue-specific. Baldwin HS, Mickanin C, Buck C (1997) Gene Ther 4: 1142-9 Transcriptional activity of the Rous sarcoma virus long terminal repeat correlates with binding of a factor to an upstream CCAAT box in vitro. Greuel BT, Sealy L, Majors JE (1990) Virology 177: 33-43 Identification of a third protein factor which binds to the Rous sarcoma virus LTR enhancer: possible homology with the serum response factor. Boulden A, Sealy L (1990) Virology 174: 204-16 Two novel variants of the v-src oncogene isolated from low and high metastatic RSV-transformed hamster cells. Tatosyan A, Yatsula B, Shtutman M, Moinova E, Kaverina I, Musatkina E, Leskov K, Mizenina O, Zueva E, Calothy G, Dezélée P (1996) Virology 216: 347-56
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.